4//SEC Filing
Kalayoglu Murat 4
Accession 0001453687-24-000117
CIK 0001453687other
Filed
Oct 14, 8:00 PM ET
Accepted
Oct 15, 4:53 PM ET
Size
8.6 KB
Accession
0001453687-24-000117
Insider Transaction Report
Form 4
Kalayoglu Murat
Director10% Owner
Transactions
- Exercise/Conversion
Series A Non-Voting Convertible Preferred Stock
2024-10-11−45,551.19→ 56,402.254 total(indirect: By Trust)→ Common Stock (1,518,373 underlying) - Exercise/Conversion
Common Stock
2024-10-11+1,518,373→ 4,555,260 total(indirect: By Trust)
Holdings
- 506,377
Common Stock
Footnotes (3)
- [F1]On October 11, 2024, a trust (the "Trust") for the benefit of the reporting person's spouse and children elected to convert a portion of its shares of the issuer's Series A Non-Voting Convertible Preferred Stock into shares of the issuer's common stock. The remaining shares of the issuer's Series A Non-Voting Convertible Preferred Stock held by the Trust are subject to a beneficial ownership limitation.
- [F2]Shares are held by the Trust for the benefit of the reporting person's spouse and children. The reporting person's spouse is a trustee of the Trust.
- [F3]On November 13, 2023, the issuer acquired the private Delaware corporation which was then known as Cartesian Therapeutics, Inc. in accordance with the terms of an Agreement and Plan of Merger, dated November 13, 2023 (the "Merger"). These securities represent merger consideration payable as a result of the closing of the Merger and securities purchased in a private placement in November 2023.
Documents
Issuer
Cartesian Therapeutics, Inc.
CIK 0001453687
Entity typeother
Related Parties
1- filerCIK 0002000002
Filing Metadata
- Form type
- 4
- Filed
- Oct 14, 8:00 PM ET
- Accepted
- Oct 15, 4:53 PM ET
- Size
- 8.6 KB